Home/Noveeda/Dr. Peter Loudon
DP

Dr. Peter Loudon

Head of Clinical Development

Noveeda

Noveeda Pipeline

DrugIndicationPhase
NasefrinAnaphylaxisPreclinical
NVE-02PoisoningPreclinical
NVE-03Breakthrough SeizuresPreclinical
NVE-04HypoglycaemiaPreclinical